Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine
- PMID: 25835095
- DOI: 10.1586/14789450.2015.1033409
Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine
Abstract
ASXL1, ASXL2 and ASXL3 are epigenetic scaffolds for BAP1, EZH2, NCOA1, nuclear receptors and WTIP. Here, functional proteomics of the ASXL family members are reviewed with emphasis on mutation spectra, the ASXM2 domain and the plant homeodomain (PHD) finger. Copy number gains of ASXL1 occur in chromosome 20q11.2 duplication syndrome and cervical cancer. Truncation mutations of ASXLs occur in autism, Bohring-Opitz and related syndromes, hematological malignancies and solid tumors, such as prostate cancer, breast cancer and high-grade glioma, which are gain- or loss-of-function mutations. The ASXM2 domain is a binding module for androgen receptor and estrogen receptor α, while the PHD finger is a ligand of WTIP LIM domains and a putative chromatin-binding module. Phylogenetic analyses of 139 human PHD fingers revealed that ASXL PHD fingers cluster with those of BPTF, DIDO, ING1, KDM5A (JARID1A), KMT2E (MLL5), PHF2, PHF8 and PHF23. The cell context-dependent epigenetic code of ASXLs should be deciphered to develop therapeutics for human diseases.
Keywords: Forkhead-box transcription factor; acute myeloid leukemia; cardiovascular development; colorectal cancer; hepatocellular carcinoma; melanoma; microsatellite instability; myelodysplastic syndrome; ovarian cancer; pancreatic cancer.
Similar articles
-
Functional and cancer genomics of ASXL family members.Br J Cancer. 2013 Jul 23;109(2):299-306. doi: 10.1038/bjc.2013.281. Epub 2013 Jun 4. Br J Cancer. 2013. PMID: 23736028 Free PMC article. Review.
-
Identification and characterization of ASXL3 gene in silico.Int J Oncol. 2004 Jun;24(6):1617-22. Int J Oncol. 2004. PMID: 15138607
-
DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.Eur J Hum Genet. 2022 Jun;30(6):695-702. doi: 10.1038/s41431-022-01083-0. Epub 2022 Apr 1. Eur J Hum Genet. 2022. PMID: 35361921 Free PMC article.
-
The Role of Additional Sex Combs-Like Proteins in Cancer.Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a026526. doi: 10.1101/cshperspect.a026526. Cold Spring Harb Perspect Med. 2016. PMID: 27527698 Free PMC article. Review.
-
The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modifications.Cell Cycle. 2012 Jan 1;11(1):119-31. doi: 10.4161/cc.11.1.18475. Epub 2012 Jan 1. Cell Cycle. 2012. PMID: 22186017 Free PMC article.
Cited by
-
Novel compound heterozygous ASXL3 mutation causing Bainbridge-ropers like syndrome and primary IGF1 deficiency.Int J Pediatr Endocrinol. 2017;2017:8. doi: 10.1186/s13633-017-0047-9. Epub 2017 Aug 4. Int J Pediatr Endocrinol. 2017. PMID: 28785287 Free PMC article.
-
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.Nat Commun. 2018 Oct 22;9(1):4385. doi: 10.1038/s41467-018-06854-2. Nat Commun. 2018. PMID: 30349006 Free PMC article.
-
Epigenetic regulation by ASXL1 in myeloid malignancies.Int J Hematol. 2023 Jun;117(6):791-806. doi: 10.1007/s12185-023-03586-y. Epub 2023 Apr 16. Int J Hematol. 2023. PMID: 37062051 Review.
-
The Role of Avapritinib for the Treatment of Systemic Mastocytosis.Cureus. 2021 Sep 29;13(9):e18385. doi: 10.7759/cureus.18385. eCollection 2021 Sep. Cureus. 2021. PMID: 34729266 Free PMC article. Review.
-
ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res. 2017 Nov 15;77(22):6267-6281. doi: 10.1158/0008-5472.CAN-17-0570. Epub 2017 Sep 21. Cancer Res. 2017. PMID: 28935813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous